Murphy SA, Cannon CP, Wiviott SD, McCabe CH, Braunwald E. Reduction in recurrent cardiovascular events with intensive lipid- lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndrome: from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Throm- bolysis In Myocardial Infarction 22) trial. J Am Coll Cardiol. 2009;54: 2358 2362. 21. Ginsberg HN, Kris-Etherton P, Dennis B, Elmer PJ, Ershow A, Lefevre M, Pearson T, Roheim P, Ramakrishnan R, Reed R, Stewart K, Stewart P, Phillips K, Anderson N. Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA Study, protocol 1. Arterioscler Thromb Vasc Biol. 1998;18:441 449. 22. Schaefer EJ, Lamon-Fava S, Ausman LM, Ordovas JM, Clevidence BA, Judd JT, Goldin BR, Woods M, Gorbach S, Lichtenstein AH. Individual variability in lipoprotein cholesterol response to National Cholesterol Education Program Step 2 diets. Am J Clin Nutr. 1997;65:823 830. 23. Schaefer EJ, Lichtenstein AH, Lamon-Fava S, Contois JH, Li Z, Ras- mussen H, McNamara JR, Ordovas JM. Efficacy of a National Choles- terol Education Program Step 2 diet in normolipidemic and hypercho- lesterolemic middle-aged and elderly men and women. Arterioscler Thromb Vasc Biol. 1995;15:1079 1085. 24. Yu-Poth S, Zhao G, Etherton T, Naglak M, Jonnalagadda S, Kris- Etherton PM. Effects of the National Cholesterol Education Program s Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. Am J Clin Nutr. 1999;69:632 646. 25. MRC/BHF Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7 22. 26. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, Gotto AM, Greten H, Kastelein JJ, Shepherd J, Wenger NK; Treating to New Targets (TNT) Investigators. 